Midkine, a multifunctional cytokine, in patients with severe sepsis and septic shock: A pilot study

Shock

Volumn 35, Issue 5, 2011, Pages 471-477

  Krzystek Korpacka, Malgorzata ^a   Mierzchala, Magdalena ^a   Neubauer, Katarzyna ^a   Durek, Grazyna ^a   Gamian, Andrzej ^a,b,c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c WROCLAW RESEARCH CENTRE EIT   (Poland)

Author keywords

antimicrobial peptide; Biomarker; hypoxia; infection; inflammatory bowel disease; neutrophil recruitment; systemic inflammatory response syndrome

Indexed keywords

MIDKINE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE SEPSIS; GRAM POSITIVE INFECTION; HUMAN; HYPOXIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MYCOSIS; NEUTROPHIL CHEMOTAXIS; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 79955535357     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182086001     Document Type: Article

References (34)

1. Kübler A, Durek G, Zamirowska A, DuszynskaW, Palysinska B, Gaszynski W, Pluta A: Ci (Pubitemid 39546039)
2. Reddy RC, Standiford TJ: Effects of sepsis on neutrophil chemotaxis. Curr Opin Hematol 17(1):18-24, 2010.
3. Venet F, Chung C-S, Monneret G, Huang X, Horner B, Garber M, Ayala A: Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83(3): 523-535, 2008. (Pubitemid 351966861)
4. Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, Bollaerd P-E, Gibot S: The relationship between CD4+CD25+CD127j regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14:R19, 2010.
5. Bochud PY, Calandra T: Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326(7383):262-266, 2003. (Pubitemid 36169594)
6. Svensson SL, Pasupuleti M, Walse B, Malmsten M, Mörgelin M, Sjögren C, Olin AI, Collin M, Schmidtchen A, Palmer R, et al.: Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem 285(21): 16105-16115, 2010.
7. Krzystek-Korpacka M, Matusiewicz M, Banas T: Structure and function of midkine, a novel heparin-binding growth factor. Postepy Hig Med Dosw 60: 591-601, 2006.
8. Muramatsu T: Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 86(4): 410-425, 2010.
9. Wang J, Takeuchi H, Sonobe Y, Jin S, Mizuno T, Miyakawa S, Fujiwara M, Nakamura Y, Kato T, Muramatsu H, et al.: Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci USA 105(10):3915-3920, 2008. (Pubitemid 351723499)
10. Krzystek-Korpacka M, Neubauer K, Matusiewicz M: Clinical relevance of circulating midkine in ulcerative colitis. Clin Chem Lab Med 47(9):1085-1090, 2009.
11. Krzystek-Korpacka M, Neubauer K, Matusiewicz M: Circulating midkine in Crohn's disease: clinical implications. Inflamm Bowel Dis 16(2):208-215, 2010.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6): 864-874, 1992.
13. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644-1655, 1992.
14. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707-710, 1996. (Pubitemid 26254283)
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13(10):818-829, 1985. (Pubitemid 15250137)
16. Maruyama K, Muramatsu H, Ishiguro N, Muramatsu T: Midkine, a heparinbinding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50(5):1420-1429, 2004. (Pubitemid 38608063)
17. Alves-Filho JC, Benjamim C, Tavares-Murta BM, Cunha C: Failure of neutrophil migration towards infectious focus in severe sepsis: a critical event for outcome of this syndrome. Mem Inst Oswaldo Cruz 100(Suppl I):223-226, 2005. (Pubitemid 40685468)
18. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, Hayashi K, Yuzawa Y, Matsuo S, Kuzuya M, et al.: Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105(4): 489-495, 2000. (Pubitemid 30127249)
19. Takada T, Kinkori T, Muramatsu H, Hayakawa A, Torii S, Muramatsu T: Midkine, a retinoic acid-inducible heparin-binding cytokine, is a novel regulator of intracellular calcium in human neutrophils. Biochem Biophys Res Commun 241(3):756-761, 1997. (Pubitemid 28036730)
20. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, Muramatsu T: Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167(6):3463-3469, 2001. (Pubitemid 32852592)
21. Sumi Y, Muramatsu H, Takei Y, Hata K, Ueda M, Muramatsu T: Midkine, a heparin-binding growth factor promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. J Cell Sci 115(Pt 13):2659-2667, 2002. (Pubitemid 34846507)
22. Tran Q-K, Watanabe H, Le H-Y, Yang J, Takeuchi K, Kadomatsu K, Muramatsu T, Ohashi K: Midkine inhibits bradykinin-stimulated Ca2+ signaling and nitric oxide production in endothelial cells. Biochem Biophys Res Commun 276(3):830-836, 2000.
23. Fortin CF, McDonald PP, Fülöp T, Lesur O: Sepsis, leukocytes, and nitric oxide (NO): an intricate affair. Shock 33(4):344-352, 2010.
24. Hirsch T, Metzig M, Niederbichler A, Steinau HU, Eriksson E, Steinstraesser L: Role of host defense peptides of the innate immune response in sepsis. Shock 30(2):117-126, 2008.
25. Funke G, von Graevenitz A, Clarridge JE, Bernard KA: Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10(1):125-159, 1997. (Pubitemid 27042834)
26. Pasciak M, Holst O, Lindner B, Mierzchala M, Grzegorzewicz A, Mordarska H, Gamian A: Structural and serological characterization of the major glycolipid from Rothia mucilaginosa, Biochim Biophys Acta 1675(1-3):54-61, 2004. (Pubitemid 39463254)
27. Horiba M, Kadomatsu K, Yasui K, Lee JK, Takenaka H, Sumida A, Kamiya K, Chen S, Sakuma S, Muramatsu T, et al.: Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 114(16):1713-1720, 2006. (Pubitemid 44607119)
28. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA: Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279(35):37124-37132, 2004. (Pubitemid 39129063)
29. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, Huang DT, Osborn T, Stevens D, Talan DA: Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 48(1):28-54, 2006.
30. De Hertogh G, Aerssens J, Geboes KP, Geboes K: Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol 14(6):845-852, 2008. (Pubitemid 351325023)
31. Porras M, Martín MT, Yang PC, Jury J, Perdue MH, Vergara P: Correlation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation. Inflamm Bowel Dis 12(9):843-852, 2006.
32. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Banas T: Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma. Biomarkers 12(4):403-413, 2007. (Pubitemid 46952301)
33. Vignali DA, Collison LW, Workman CJ: How regulatory T cells work. Nat Rev Immunol 8(7):523-532, 2008.
34. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A: Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsisinduced immunoparalysis. Crit Care Med 31(7):2068-2071, 2003. (Pubitemid 36900766)